C, G., M, M., T, L., F, F., P, M., P, B., . . . E, G. (2025). Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials. Haematologica, 110(1), 206. https://doi.org/10.3324/haematol.2024.285416
Chicago Style (17th ed.) CitationC, Gonzalez-Gil, et al. "Contribution of Copy Number to Improve Risk Stratification of Adult T-cell Acute Lymphoblastic Leukemia Patients Enrolled in Measurable Residual Disease-oriented Trials." Haematologica 110, no. 1 (2025): 206. https://doi.org/10.3324/haematol.2024.285416.
MLA (9th ed.) CitationC, Gonzalez-Gil, et al. "Contribution of Copy Number to Improve Risk Stratification of Adult T-cell Acute Lymphoblastic Leukemia Patients Enrolled in Measurable Residual Disease-oriented Trials." Haematologica, vol. 110, no. 1, 2025, p. 206, https://doi.org/10.3324/haematol.2024.285416.